[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100465349":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":22,"centralContacts":27,"locations":32,"responsibleParty":49,"collaborators":10,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":10,"enrollmentInfo":62,"targetDuration":10,"studyType":65,"phases":10,"briefSummary":66,"conditions":67,"keywords":10,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Qianfoshan Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Platform follow-up cohort",null,"This cohort will be managed and follow-up by patients' whole process follow-up platform. The patients can report the symptoms, get the reminder of the hospital visit, get the reminder of medicine taking, get the information of patients education.",[13],"Other: Patients' whole process follow-up and management platform",{"label":15,"type":10,"description":16,"interventionNames":10},"Routine follow-up cohort","This cohort will be managed and follow-up by the investigators or nurses. This cohort will take the routine follow-up and management way by the hospital.",[18],{"type":6,"name":19,"description":20,"armGroupLabels":21,"otherNames":10},"Patients' whole process follow-up and management platform","Patients' whole process follow-up and management platform is a software for the patients and investigators. This platform will use to collect patients' information when they are out of patients and will provide the patients' education materials.",[9],[23],{"name":24,"affiliation":25,"role":26},"Jiandong ZHANG","Shandong First Medical University","PRINCIPAL_INVESTIGATOR",[28],{"name":24,"role":29,"phone":30,"phoneExt":10,"email":31},"CONTACT","(+86531)89268118","zhangjd165@sina.com",[33],{"facility":34,"status":35,"city":36,"state":37,"zip":10,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"The First Affiliated Hospital of Shandong First Medical University","RECRUITING","Jinan","Shandong","China","CN",{"type":41,"coordinates":42},"Point",[43,44],116.99722,36.66833,{"lat":44,"lon":43},[47],{"name":24,"role":29,"phone":48,"phoneExt":10,"email":31},"+8653189268118",{"type":26,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Jiandong Zhang","Director of Oncology Radiotherapy Department","100465349","patients-whole-process-follow-up-managementhope-1-100465349",false,"NCT05339568","Patient's Whole Process Follow-up Management(HOPE-1)","A Multicenter, Randomized, Open, Parallel Grouping, Investigator-initiated Study Evaluating the Long-term Benefit of Patients With Locally Advanced\u002FMetastatic Non-small Cell Lung Cancer Followed up Using a Patient-wide Management Platform","HOPE-1","Inclusion Criteria:\n\n1. Fully understand the research and voluntarily sign the informed consent form (ICF)\n2. Male or female subjects who are over 18 years old (inclusive) at the time of signing the informed consent form.\n3. The subject is diagnosed pathologically or cytologically with non-small cell lung cancer(NSCLC).\n4. According to the 8th edition of the American Joint Committee on Cancer \\[AJCC\\], it is classified as stage IIB, stage III, stage IV NSCLC.\n5. Not suitable for radical treatment or refuse surgery.\n6. The life expectancy is not less than 3 months.\n7. Be able to use a smartphone.\n\nExclusion Criteria:\n\n1. Patients with mental illness.\n2. Presence of any other malignant tumor.\n3. Patients who are expected to undergo radical surgery.\n4. Currently participating in clinical trials.\n5. Subjects who judged by the investigator to be unsuitable to participate in the trial.","ALL","18 Years",{"count":63,"type":64},1268,"ESTIMATED","OBSERVATIONAL","Our project is going to explore whether management and follow-up of locally advanced\u002Fmetastatic patients using the patient process management platform can prolong patient survival and improve patient quality of life.",[68,69],"Locally Advanced Non-Small Cell Lung Cancer","Metastatic NSCLC","2022-09-05",{"date":72,"type":73},"2022-09-08","ACTUAL",{"date":75,"type":73},"2022-05-22",{"date":77,"type":64},"2030-08-20",{"name":5,"class":6},1]